Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference103 articles.
1. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of
myocardial infarction and death from cardiovascular causes. N Engl J Med.
2007;356:2457–71.
2. Mahaffey KW, Hafley G, Dickerson S, et al. Results of a
reevaluation of cardiovascular outcomes in the RECORD trial. Am Heart J.
2013;166(240–249):e241.
3. White WB, Cannon CP, Heller SR, et al. Alogliptin after acute
coronary syndrome in patients with type 2 diabetes. N Engl J Med.
2013;369:1327–35.
4. Green JB, Bethel MA, Armstrong PW, et al. Effect of sitagliptin on
cardiovascular outcomes in type 2 diabetes. N Engl J Med.
2015;373:232–42.
5. Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and
cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med.
2013;369:1317–26.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献